Imaging findings and differential diagnosis of hepatic sinusoidal occlusion syndrome and Budd-Chiari syndrome

Objective To retrospectively analyze the clinical and imaging manifestations differential points between hepatic sinusoidal obstruction syndrome (SOS) and Budd-Chiari syndrome (BCS). Material The clinical symptoms, laboratory examination and imaging findings of 15 cases of hepatic sinusoidal obstruction syndrome and 33 cases of Budd-Chiari syndrome were statistically analyzed, find the identification points. The study used the Fisher test, P values of 0.05 or less were considered to indicate significant differences. The retrospective study was approved by the hospital's ethics committee. Results Laboratory tests: There were significant differences in total protein reduction rate (66.7% vs 9.1%, p༜0.01), albumin reduction rate (66.7% vs 9.1%, p༜0.01), Gamma-glutamyltransferase elevation rate (100% vs 6.1%, P༜0.01), alkaline phosphatase elevation rate (60% vs 6.1%, p༜0.01), and abnormal rate of prothrombin time (100% vs 21.2%, p༜0.01) between the two groups (BCS vs SOS). It also indicates that the liver function of SOS patients is more seriously impaired. Image findings: The following image findings were observed significant more frequently in SOS than in BCS and were statistically significant: gallbladder wall thickening (66.7% vs 78.2%, p༜0.01), ascites (80% vs 27.3%, p༜0.01), cloverleaf or claw-like shapes (80% vs 0%, p༜0.01). The following images appeared more frequently in BCS than in BCS and were statistically significant: caudate lobe enlargement (33.3% vs 75.8%, p༜0.01), collateral circulation (46.7% vs 93.9%, p༜0.01), diffuse patchy enhancement (20% vs 93.9%, p༜0.01), homogeneous in delayed phase (13.3% vs 90.1%, p༜0.01). Conclusion To Identification of SOS and BCS should be based on the patient's laboratory examination and imaging findings to improve diagnostic accuracy.

[1]  F. Ravaioli,et al.  Diagnosis and Treatment of VOD/SOS After Allogeneic Hematopoietic Stem Cell Transplantation , 2020, Frontiers in Immunology.

[2]  Lingling Meng,et al.  Clinical characteristics, CT signs, and pathological findings of Pyrrolizidine alkaloids-induced sinusoidal obstructive syndrome: a retrospective study , 2020, BMC Gastroenterology.

[3]  V. Vilgrain,et al.  CT and MR imaging of chemotherapy-induced hepatopathy , 2019, Abdominal Radiology.

[4]  Jianming Xu,et al.  Quantitative Analysis of CT Images in Patients with Pyrrolizidine Alkaloid-Induced Sinusoidal Obstruction Syndrome , 2019, Scientific Reports.

[5]  T. Bai,et al.  Gadoxetic Acid-Enhanced Hepatobiliary-Phase Magnetic Resonance Imaging for Pyrrolizidine Alkaloid-Induced Hepatic Sinusoidal Obstruction Syndrome and Association with Liver Function , 2019, Scientific Reports.

[6]  Varun Bansal,et al.  Budd-Chiari syndrome: imaging review. , 2018, The British journal of radiology.

[7]  A. Schulz,et al.  Diagnosis and severity criteria for sinusoidal obstruction syndrome/veno-occlusive disease in pediatric patients: a new classification from the European society for blood and marrow transplantation , 2017, Bone Marrow Transplantation.

[8]  M. Ronot,et al.  Diagnosis of Budd–Chiari syndrome , 2018, Abdominal Radiology.

[9]  T. Genet,et al.  Diagnostic performance of contrast-enhanced CT-scan in sinusoidal obstruction syndrome induced by chemotherapy of colorectal liver metastases: Radio-pathological correlation. , 2017, European journal of radiology.

[10]  X. Hou,et al.  Diagnostic performance of Contrast-enhanced CT in Pyrrolizidine Alkaloids-induced Hepatic Sinusoidal Obstructive Syndrome , 2016, Scientific Reports.

[11]  M. Abecassis,et al.  Revised diagnosis and severity criteria for sinusoidal obstruction syndrome/veno-occlusive disease in adult patients: a new classification from the European Society for Blood and Marrow Transplantation , 2016, Bone Marrow Transplantation.

[12]  O. Matsui,et al.  Correlation between Gd-EOB-DTPA-enhanced MR imaging findings and OATP1B3 expression in chemotherapy-associated sinusoidal obstruction syndrome , 2015, Abdominal Imaging.

[13]  Min Ju Kim,et al.  Hepatic Parenchymal Heterogeneity on Contrast-enhanced CT Scans Following Oxaliplatin-based Chemotherapy: Natural History and Association with Clinical Evidence of Sinusoidal Obstruction Syndrome. , 2015, Radiology.

[14]  J. Crawford,et al.  Sinusoidal obstruction syndrome (hepatic veno-occlusive disease). , 2014, Journal of Clinical and Experimental Hepatology.

[15]  Yi-Xiang J. Wang,et al.  Hepatic Sinusoidal Obstruction Syndrome Caused by Herbal Medicine: CT and MRI Features , 2014, Korean journal of radiology.

[16]  Hong Gao,et al.  Tusanqi and hepatic sinusoidal obstruction syndrome , 2014, Journal of digestive diseases.

[17]  G. Lin,et al.  Definitive diagnosis of hepatic sinusoidal obstruction syndrome induced by pyrrolizidine alkaloids , 2012, Journal of digestive diseases.

[18]  G. Lin,et al.  Hepatic sinusoidal obstruction syndrome associated with consumption of Gynura segetum. , 2011, Journal of hepatology.

[19]  L. Rubbia‐Brandt,et al.  Sinusoidal obstruction syndrome. , 2010, Clinics in liver disease.

[20]  J. Huo,et al.  Hepatic veno-occlusive disease associated with toxicity of pyrrolizidine alkaloids in herbal preparations. , 2010, The Netherlands journal of medicine.

[21]  Allen R. Chen,et al.  Hepatic veno-occlusive disease following stem cell transplantation: incidence, clinical course, and outcome. , 2010, Biology of blood and marrow transplantation : journal of the American Society for Blood and Marrow Transplantation.

[22]  Y. Bayraktar,et al.  Budd-Chiari syndrome: etiology, pathogenesis and diagnosis. , 2007, World journal of gastroenterology.

[23]  Yan Jiang,et al.  Deacetylclivorine: A Gender-Selective Metabolite of Clivorine Formed in Female Sprague-Dawley Rat Liver Microsomes , 2007, Drug Metabolism and Disposition.

[24]  Sukru Mehmet Erturk,et al.  CT features of hepatic venoocclusive disease and hepatic graft-versus-host disease in patients after hematopoietic stem cell transplantation. , 2006, AJR. American journal of roentgenology.

[25]  D. Mitchell,et al.  Budd‐chiari syndrome: Spectrum of appearances of acute, subacute, and chronic disease with magnetic resonance imaging , 2000, Journal of magnetic resonance imaging : JMRI.

[26]  M. Kami,et al.  Risk factors for hepatic veno-occlusive disease after bone marrow transplantation: retrospective analysis of 137 cases at a single institution , 1997, Bone Marrow Transplantation.

[27]  K. Tınaztepe,et al.  Veno-occlusive disease of the liver. , 1967, The Turkish journal of pediatrics.

[28]  H. Stein Veno-occlusive Disease of Liver in African Children , 1957, British medical journal.